PSY 470 Topic 4 treatment evidence review example

Abnormal Psychology Grand Canyon University Free custom sample in 24 to 48h

This PSY 470 Topic 4 sample paper reviews the evidence for cognitive-behavioral therapy for panic disorder, reporting outcomes at the size found. It was prepared for GCU PSY 470, Abnormal Psychology, catalog code PSY-470, part of Grand Canyon University's BS in Psychology. Sessions, components and interoceptive exposure are named precisely. Barlow and colleagues' 312-person trial shows about half responding against a fifth on placebo, with more durable gains. Hofmann and colleagues summarize meta-analyses, trial limits are stated, Wampold's common factors frame similar outcomes, and the review explains why advice built on avoidance and safety objects persists despite maintaining panic. All cited sources are real.

CoursePSY 470 Abnormal Psychology
TopicTopic 4
Paper typeTreatment evidence review
LengthAbout 970 words, 2 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramBS in Psychology
UpdatedOctober 2026

Free sample paper for PSY 470 Topic 4

1

What the Trials Show for Cognitive-Behavioral Therapy for Panic Disorder, at the Size Reported

[Author Name]

College of Humanities and Social Sciences, Grand Canyon University

PSY-470: Abnormal Psychology

Topic 4 Treatment Evidence Review

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states the review's scope. The sources are real; the review advises no reader about their own care.
2

What the Trials Show for Cognitive-Behavioral Therapy for Panic Disorder, at the Size Reported

The Treatment, Named Precisely

This review examines cognitive-behavioral therapy for panic disorder in adults. A label like therapy covers procedures with very different records, so the treatment is named precisely. In the protocol most often tested, a trained therapist meets the client weekly for about eleven to fifteen sessions of roughly fifty minutes. Sessions combine several components: education about the physiology of panic and the cycle in which bodily sensations are misread as signs of danger; breathing retraining; cognitive work on catastrophic interpretations, such as reading a pounding heartbeat as a sign of cardiac arrest; interoceptive exposure, in which the client deliberately produces feared sensations, for example by spinning in a chair or breathing through a straw, until they no longer provoke alarm; and gradual exposure to situations the client has avoided. Between sessions the client practices these skills at home.

Evidence From a Controlled Trial

Findings are reported with the design that produced them. Barlow et al. (2000) conducted a randomized controlled trial at four sites, assigning 312 adults with panic disorder to cognitive-behavioral therapy alone, the antidepressant imipramine alone, a pill placebo, or combinations. After twelve weeks of acute treatment, cognitive-behavioral therapy and imipramine each outperformed placebo, and neither was clearly superior to the other. In the intent-to-treat analysis, which counts everyone assigned regardless of whether they completed treatment, roughly half of those receiving cognitive-behavioral therapy were classified as responders, compared with about a fifth of those receiving placebo. Six months after treatment ended, people who had responded to cognitive-behavioral therapy were more likely to have maintained their gains than those who had responded to imipramine alone.

A trial with a comparison group is different from a series of satisfied clients. A clinician who reports that most of their clients with panic improved cannot tell how many would have improved anyway, since panic symptoms fluctuate and people often seek help at their worst. The placebo group in the trial provides that comparison: some improvement occurred without the active treatment, and the effect of cognitive-behavioral therapy is the difference above it.

Effects at the Size Reported

Hofmann et al. (2012) brought together meta-analyses covering a wide range of problems and reported that its efficacy was strongly supported for anxiety disorders, including panic disorder, with effect sizes relative to control conditions that were generally medium to large. Effects are smaller when the comparison is an active alternative treatment than when it is a waiting list or no treatment.

The figures that matter alongside the effect sizes are the proportions who do not benefit. In trials of this kind, a substantial minority of those who complete treatment do not respond, and a further share leave treatment early. Dropout in cognitive-behavioral therapy for panic has commonly been reported in the range of one in five or more. A treatment can be the best available and still leave many people unhelped.

Table 1

Evidence on Cognitive-Behavioral Therapy for Panic Disorder

FindingSourceWhat it shows
CBT and imipramine each outperformed placebo at 12 weeksBarlow et al. (2000), randomized trial, 312 adultsEffect above improvement without active treatment
About half responded to CBT in intent-to-treat analysisBarlow et al. (2000)Many benefit; many do not
CBT gains held better once sessions stoppedBarlow et al. (2000)Advantage in maintenance
Medium to large effects for anxiety disordersHofmann et al. (2012), review of meta-analysesStrong support relative to controls
Similar outcomes across bona fide therapiesWampold (2015)Shared factors may account for much of the effect

What the Trials Cannot Say

Controlled trials have limits a review should name. Participants in them are selected: people with severe depression, substance use problems or other complications are often excluded, so trial samples may be easier to treat than people seen in ordinary clinics. Therapists in trials are trained and supervised closely, which may not reflect routine practice. And the trials measure outcomes over months, not years. Studies in community settings suggest the treatment still helps outside trials, but often less, which is the gap between efficacy under ideal conditions and effectiveness in practice.

When Approaches Perform Similarly

Where two approaches perform similarly, a review should consider what they share rather than declare a winner. Wampold (2015) reviewed evidence that factors common to psychotherapies, including the therapeutic alliance, the therapist's empathy, the client's expectations of improvement and a coherent explanation of the problem, explain a large share of what makes psychotherapy helpful, and that well-delivered therapies intended to be therapeutic often produce similar outcomes. That view does not mean specific techniques are irrelevant; interoceptive exposure has a plausible mechanism for panic in particular. It does mean that comparisons between therapies should examine what both provide, not only what differs.

Why the Popular Version Persists

A popular version of panic treatment holds that the person should avoid triggers, carry a paper bag or medication everywhere and learn to relax whenever symptoms begin. That version persists because it brings quick relief: avoiding a crowded store prevents the panic that might happen there, and carrying a safety object reduces worry. But the relief is what maintains the disorder. Each avoided situation reinforces the belief that it was dangerous, and safety behaviors deny the person the chance to discover that the dreaded outcome never arrives. Cognitive-behavioral therapy works in the opposite direction, by approaching rather than avoiding, which is why it can feel counterintuitive and is less often what people try first.

What the Review Concludes

The evidence supports cognitive-behavioral therapy as an effective treatment for panic disorder, comparable to medication in the short term and with an advantage in durability, at effect sizes that are substantial but leave many people without full benefit. This review reports outcomes; it advises no reader about their own care, which belongs with a qualified clinician.

References

Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA, 283(19), 2529-2536. https://doi.org/10.1001/jama.283.19.2529

Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427-440. https://doi.org/10.1007/s10608-012-9476-1

Wampold, B. E. (2015). How important are the common factors in psychotherapy? An update. World Psychiatry, 14(3), 270-277. https://doi.org/10.1002/wps.20238

What the PSY 470 Topic 4 instructions ask for

Topic 4 in PSY-470 sets students the task of weighing a treatment's evidence. Strong reviews name the treatment precisely, including what a session contains, how many there are and who delivers them, and report findings with the designs that produced them, distinguishing controlled trials from collections of satisfied clients. Students should give effects at the size reported alongside the proportion who did not improve and the proportion who left. Where approaches perform similarly, the review should consider what they share rather than declare a winner, explain why the popular version persists and advise no reader about their own care. A review may conclude that a popular treatment is weakly supported, provided the evidence is shown rather than asserted.

Inside the PSY 470 Topic 4 example

The finished review reports outcomes rather than endorsing an approach. It names the treatment precisely, meaning what a session contains, how many there are and who delivers them, because a label like therapy covers procedures with very different records. Findings arrive with the design that produced them, and the review distinguishes a trial with a comparison group from a series of satisfied clients. Effects are given at the size reported, alongside the proportion of people who did not improve and the proportion who left. Where two approaches perform similarly, the review considers what they share instead of declaring a winner. It closes on why the popular version persists, and it advises no reader about their own care.

Reading the PSY 470 Topic 4 rubric

Faculty reward outcomes reported, not approaches endorsed. An Excellent review names sessions, components and interoceptive exposure. Credit goes to Barlow, Gorman, Shear and Woods's randomized trial with intent-to-treat response rates against placebo and maintenance, and to Hofmann and colleagues' review of meta-analyses, in a table. The rubric values reporting nonresponse and dropout and naming what trials cannot say about routine practice. Strong reviews use Wampold on common factors when outcomes are similar. Top marks go to explaining why avoidance and safety objects feel helpful yet maintain panic.

PSY 470 Topic 4 help before you submit

The loss that decides this topic is a review arguing from testimony, since somebody feeling better after a course of treatment is not a trial result. Papers reporting that an approach is effective without saying effective compared with what have left out the comparison the whole design rests on. Quoting a difference as reliable while omitting its magnitude leaves a reader unable to tell whether anybody would notice the change. Reviews silent on dropout hide the commonest reason a treatment looks stronger than it is. Confusing how widely an approach is offered with how well it performs is exactly the confusion this topic sets up. A review that ends by recommending a treatment to the reader has stepped outside the assignment and outside what a coursework paper can responsibly do.

Get a PSY-470 Topic 4 example written to your instructions

Send us the PSY-470 Topic 4 instructions, the rubric in your classroom and the treatment or disorder your section chose. A custom example is written to those criteria, with the procedure specified, the trials ranked by design, effect sizes and dropout reported, and popularity explained on its own terms, inside 24 to 48 hours. The first one is free.

More PSY 470 papers and BS in Psychology samples

PSY 470 Topic 4 questions, answered

Why does a comparison group matter so much?

Because many conditions improve without treatment, and a paper cannot tell recovery apart from effect without something to measure against. A waiting list, usual care or an active alternative each give the result a reference point. Reviews built on before and after scores in a single group report change, and change is not the same as a treatment having caused it.

Can I conclude that a widely used treatment is unsupported?

Yes, if you show it. A review reporting few controlled trials, small samples or results that shrink under stricter designs has grounds for that conclusion, and saying so with citations is better work than a diplomatic summary. What the criteria penalize is the verdict arriving without the evidence, in either direction.

Does this page tell me which treatment to choose?

No, and neither should the paper you write from it. Everything here concerns how an academic review is put together and where its marks sit, not what any individual should do about their own health. Decisions of that kind belong with a qualified clinician who knows the person, and a coursework example is not a substitute for one.

Where can I find a free PSY 470 Topic 4 sample paper?

Every part of the treatment review appears on this page: the treatment named, the controlled trial, effects at their size, what trials cannot say, shared factors, why the popular version persists and the conclusion. Post your PSY 470 Topic 4 prompt and get a free review.

Why does a placebo group matter in PSY 470 Topic 4?

Panic symptoms fluctuate, and people often seek help at their worst, so some improve anyway. A placebo group shows how much improvement happens without the active treatment.